These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 29512735)

  • 81. Fastidious Detection of Circulating Tumor DNA Mutations in Residual Breast Cancer Disease for Ultimate Analytical Sensitivity and Specificity.
    Chiu RWK
    Clin Chem; 2020 Jul; 66(7):866-867. PubMed ID: 32215639
    [No Abstract]   [Full Text] [Related]  

  • 82. The Value of Combined Large Format Histopathology Technique to Assess the Surgically Removed Breast Tissue following Neoadjuvant Chemotherapy: A Single Institution Study of 40 Cases.
    Ibarra JA
    Int J Breast Cancer; 2012; 2012():361707. PubMed ID: 23119168
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Two-photon imaging reveals histopathological changes in the gastric tumor microenvironment induced by neoadjuvant treatment.
    Li L; Hong S; Kang D; Huang X; Zhang S; Zhang Z; Zhou Y; Chen J
    Biomed Opt Express; 2023 Oct; 14(10):5085-5096. PubMed ID: 37854573
    [TBL] [Abstract][Full Text] [Related]  

  • 84. A Molecular Imaging "Skin A Time-resolving Intraoperative Imager for Microscopic Residual Cancer Detection Using Enhanced Upconverting Nanoparticles.
    Najafiaghdam H; Papageorgiou P; Torquato NA; Tajon CA; Zhang H; Park C; Boser B; Cohen BE; Anwar M
    Annu Int Conf IEEE Eng Med Biol Soc; 2018 Jul; 2018():1-4. PubMed ID: 30440277
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Three-dimensional Image-based Mechanical Modeling for Predicting the Response of Breast Cancer to Neoadjuvant Therapy.
    Weis JA; Miga MI; Yankeelov TE
    Comput Methods Appl Mech Eng; 2017 Feb; 314():494-512. PubMed ID: 28042181
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Improving Reporting of Tumor Size in Synoptic Reports.
    Renshaw AA; Gould EW
    Arch Pathol Lab Med; 2021 Aug; 145(8):969-972. PubMed ID: 33186987
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Can We Hang Our Hats on One Percent?
    LeVasseur N; Gelmon KA
    Oncologist; 2018 Jun; 23(6):642-644. PubMed ID: 29728470
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Responding to: Parallel analysis and MBI-HSS.
    Colomb Med (Cali); 2013 Oct; 44(4):248. PubMed ID: 24892244
    [No Abstract]   [Full Text] [Related]  

  • 89. The residual cancer burden index as a valid prognostic indicator in breast cancer after neoadjuvant chemotherapy.
    Xu X; Zhao W; Liu C; Gao Y; Chen D; Wu M; Li C; Wang X; Song X; Yu J; Liu Z; Yu Z
    BMC Cancer; 2024 Jan; 24(1):13. PubMed ID: 38166846
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Radionuclide-Based Imaging of Breast Cancer: State of the Art.
    Li H; Liu Z; Yuan L; Fan K; Zhang Y; Cai W; Lan X
    Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771622
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Molecular Breast Imaging-guided Percutaneous Biopsy of Breast Lesions: A New Frontier on Breast Intervention.
    Adrada BE; Moseley T; Kappadath SC; Whitman GJ; Rauch GM
    J Breast Imaging; 2020; 2(5):484-491. PubMed ID: 33015619
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Meta-analysis of magnetic resonance imaging in detecting residual breast cancer after neoadjuvant therapy.
    Marinovich ML; Houssami N; Macaskill P; Sardanelli F; Irwig L; Mamounas EP; von Minckwitz G; Brennan ME; Ciatto S
    J Natl Cancer Inst; 2013 Mar; 105(5):321-33. PubMed ID: 23297042
    [TBL] [Abstract][Full Text] [Related]  

  • 93. The role of molecular breast imaging in predicting complete tumor response to treatment and residual tumor extent following neoadjuvant therapy.
    Nuvoli S; Galassi S; Gelo I; Rocchitta G; Fancellu A; Serra PA; Madeddu G; Spanu A
    Oncol Rep; 2018 May; 39(5):2055-2062. PubMed ID: 29512735
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Assessment of Residual Disease With Molecular Breast Imaging in Patients Undergoing Neoadjuvant Therapy: Association With Molecular Subtypes.
    Menes TS; Golan O; Vainer G; Lerman H; Schneebaum S; Klausner J; Even-Sapir E
    Clin Breast Cancer; 2016 Oct; 16(5):389-395. PubMed ID: 27282845
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Comparison of
    Hunt KN; Conners AL; Goetz MP; O'Connor MK; Suman V; Kalari K; Weinshilboum R; Wang L; Carter J; McLaughlin S; Aspitia AM; Gray R; Northfelt D; Boughey JC
    AJR Am J Roentgenol; 2019 Oct; 213(4):932-943. PubMed ID: 31166752
    [No Abstract]   [Full Text] [Related]  

  • 96. Dedicated breast PET for detecting residual disease after neoadjuvant chemotherapy in operable breast cancer: A prospective cohort study.
    Sasada S; Masumoto N; Goda N; Kajitani K; Emi A; Kadoya T; Okada M
    Eur J Surg Oncol; 2018 Apr; 44(4):444-448. PubMed ID: 29396328
    [TBL] [Abstract][Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.